RA Capital Management »

Q32 Bio shares owned by RA Capital Management

Quarter-by-quarter ownership of Q32 Bio (QTTB) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Q32 Bio

Tip: Access up to 7 years of quarterly data

All positions including Q32 Bio held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Q32 Bio by RA Capital Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $30M 2.3M 12.74

More positions owned by RA Capital Management

Ascendis Pharma A/s Common Stock (ASND)
Parabilis Medicines Common Stock
Rhythm Pharmaceuticals Common Stock (RYTM)
Vaxcyte Common Stock (PCVX)
Sionna Therapeutics Common Stock (SION)
Tyra Biosciences Common Stock (TYRA)
Edgewise Therapeutics Common Stock (EWTX)
Newamsterdam Pharma Co Nv Common Stock (NAMS)
Hemab Therapeutics Holdings Common Stock
Septerna Common Stock (SEPN)
Bicara Therapeutics Common Stock (BCAX)
Mineralys Therapeutics Common Stock (MLYS)
Gh Research Common Stock (GHRS)
Disc Medicine Common Stock (IRON)
Spyglass Pharma Common Stock (SGP)

View all positions for RA Capital Management

Top funds holding Q32 Bio

OrbiMed Advisors
Atlas Venture Life Science Advisors
BVF
RA Capital Management
Point72 Asset Management
Opaleye Management
Ikarian Capital
Vanguard Capital Management
Acorn Capital Advisors
American Century Companies
Sanofi
Acadian Asset Management
Boothbay Fund Management
Renaissance Technologies
Jane Street

View all funds holding Q32 Bio